Versant Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
Versant Capital Management's MLAB Position: Q3 2026 in Review
Versant Capital Management held its Mesa Laboratories (MLAB) position steady in Q3 2026 at 139 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2017.
Versant Capital Management first reported a position in MLAB in Q1 2020 and has held it in 22 quarters since. 184 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.
- Versant Capital Management held 139 shares of Mesa Laboratories worth $18.1K as of Q3 2026.
- Versant Capital Management left its Mesa Laboratories share count unchanged in Q3 2026.
- Mesa Laboratories made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2017 holding.
- Versant Capital Management first reported a position in Mesa Laboratories in Q1 2020 and has held it in 22 quarters since.
- 184 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.